Authors:
Suzuma, T
Sakurai, T
Yoshimura, G
Umemura, T
Tamaki, T
Yoshimasu, T
Naito, Y
Citation: T. Suzuma et al., Pamidronate-induced remission of pain associated with hypertrophic pulmonary osteoarthropathy in chemoendocrine therapy-refractory inoperable metastatic breast carcinoma, ANTI-CANC D, 12(9), 2001, pp. 731-734
Authors:
Yang, QF
Sakurai, T
Yoshimura, G
Mori, I
Nakamura, M
Nakamura, Y
Suzuma, T
Tamaki, T
Umemura, T
Kakudo, K
Citation: Qf. Yang et al., Hypermethylation does not account for the frequent loss of the retinoic acid receptor beta 2 in breast carcinoma, ANTICANC R, 21(3B), 2001, pp. 1829-1833
Authors:
Yang, QF
Yoshimura, G
Sakurai, T
Nakamura, M
Nakamura, Y
Shan, L
Suzuma, T
Tamaki, T
Umemura, T
Mori, I
Kakudo, K
Citation: Qf. Yang et al., Allelic loss of chromosome 3p24 correlates with tumor progression rather than with retinoic acid receptor beta 2 expression in breast carcinoma, BREAST CANC, 70(1), 2001, pp. 39-45
Authors:
Yang, QF
Mori, I
Shan, L
Nakamura, M
Nakamura, Y
Utsunomiya, H
Yoshimura, G
Suzuma, T
Tamaki, T
Umemura, T
Sakurai, T
Kakudo, K
Citation: Qf. Yang et al., Biallelic inactivation of retinoic acid receptor beta 2 gene by epigeneticchange in breast cancer, AM J PATH, 158(1), 2001, pp. 299-303
Authors:
Yang, QF
Sakurai, T
Shan, L
Yu, ZG
Yoshimura, G
Suzuma, T
Tamaki, T
Umemura, T
Nakamura, M
Nakamura, Y
Mori, I
Kakudo, K
Citation: Qf. Yang et al., Novel polymorphisms of prostate-specific antigen (PSA) gene associated with PSA mRNA expression in breast cancer, J HUM GENET, 45(6), 2000, pp. 363-366
Authors:
Suzuma, T
Sakurai, T
Yoshimura, G
Umemura, T
Tamaki, T
Naito, Y
Citation: T. Suzuma et al., Paclitaxel-induced remission in docetaxel-refractory anthracycline-pretreated metastatic breast cancer, ANTI-CANC D, 11(7), 2000, pp. 569-571
Authors:
Yang, QF
Sakurai, T
Yoshimura, G
Takashi, Y
Suzuma, T
Tamaki, T
Umemura, T
Nakamura, Y
Nakamura, M
Utsunomiya, H
Mori, I
Kakudo, K
Citation: Qf. Yang et al., Overexpression of p27 protein in human breast cancer correlates with in vitro resistance to doxorubicin and mitomycin C, ANTICANC R, 20(6B), 2000, pp. 4319-4322
Authors:
Yang, QF
Sakurai, T
Yoshimura, G
Shan, L
Suzuma, T
Tamaki, T
Umemura, T
Kokawa, Y
Nakamura, Y
Nakamura, M
Tang, WH
Utsunomiya, H
Mori, I
Kakudo, K
Citation: Qf. Yang et al., Expression of Bcl-2 but not Bax or p53 correlates with in vitro resistanceto a series of anticancer drugs in breast carcinoma, BREAST CANC, 61(3), 2000, pp. 211-216
Authors:
Yang, QF
Sakurai, T
Jing, XF
Utsunomiya, H
Shan, L
Nakamura, Y
Nakamura, M
Oura, S
Suzuma, T
Yoshimura, G
Umemura, T
Kokawa, Y
Kakudo, K
Citation: Qf. Yang et al., Expression of Bcl-2, but not Bax, correlates with estrogen receptor statusand tumor proliferation in invasive breast carcinoma, PATHOL INT, 49(9), 1999, pp. 775-780
Authors:
Yang, QF
Shan, L
Yoshimura, G
Taniguchi, E
Suzuma, T
Nakamura, Y
Nakamura, M
Utsunomiya, H
Tang, WH
Sakurai, T
Kakudo, K
Citation: Qf. Yang et al., Thymidine phosphorylase expression in invasive carcinoma: Correlations with clinicopathologic variables and in vitro chemosensitivity to 5-fluorouracil, ANTICANC R, 19(6C), 1999, pp. 5543-5546